JPMorgan Chase & Co’s Context Therapeutics CNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-80
| Closed | -$49 | – | 6235 |
|
|
2025
Q1 | $49 | Sell |
80
-86
| -52% | -$53 | ﹤0.01% | 6110 |
|
|
2024
Q4 | $174 | Sell |
166
-7
| -4% | -$7 | ﹤0.01% | 5874 |
|
|
2024
Q3 | $339 | Buy |
+173
| New | +$339 | ﹤0.01% | 5771 |
|
|
2024
Q2 | – | Sell |
-33
| Closed | -$46 | – | 6332 |
|
|
2024
Q1 | $46 | Buy |
33
+10
| +43% | +$14 | ﹤0.01% | 6041 |
|
|
2023
Q4 | $26 | Buy |
23
+7
| +44% | +$8 | ﹤0.01% | 6259 |
|
|
2023
Q3 | $24 | Buy |
+16
| New | +$24 | ﹤0.01% | 6170 |
|